Next Article in Journal
Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Look at the Approved and Emerging Therapies
Next Article in Special Issue
Assessment of a Manual Method versus an Automated, Probability-Based Algorithm to Identify Patients at High Risk for Pharmacogenomic Adverse Drug Outcomes in a University-Based Health Insurance Program
Previous Article in Journal
Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients
Previous Article in Special Issue
Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams
 
 
Article

Article Versions Notes

J. Pers. Med. 2021, 11(12), 1343; https://doi.org/10.3390/jpm11121343
Action Date Notes Link
article xml file uploaded 10 December 2021 07:02 CET Original file -
article xml uploaded. 10 December 2021 07:02 CET Update https://www.mdpi.com/2075-4426/11/12/1343/xml
article pdf uploaded. 10 December 2021 07:02 CET Version of Record https://www.mdpi.com/2075-4426/11/12/1343/pdf
article html file updated 10 December 2021 07:04 CET Original file -
article html file updated 10 December 2021 07:06 CET Update -
article html file updated 30 July 2022 21:28 CEST Update https://www.mdpi.com/2075-4426/11/12/1343/html
Back to TopTop